Caracemide (NSC-253272) inhibits the enzyme ribonucleotide reductase of Escherichia coli. Caracemide is a novel anticancer agent derived from a hydroxamic acid and has demonstrated to produce severe central nervous system (CNS) toxicity[1][2].
Molecular Weight:
189.17
Purity:
95
CAS Number:
[81424-67-1]
Formula:
C6H11N3O4
Target:
Bacterial,DNA/RNA Synthesis
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
